Innocent Information

Microfluidic Market to Surpass US$ 13.8 Billion Threshold by 2025 | CMI Research

 Breaking News
  • No posts were found

Microfluidic Market to Surpass US$ 13.8 Billion Threshold by 2025 | CMI Research

August 20
19:52 2019
Microfluidic Market to Surpass US$ 13.8 Billion Threshold by 2025 | CMI Research

Rising demand for point-of-care testing to augment microfluidic market growth
The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to witness a robust CAGR of 19.4% over the forecast period (2017–2025)

Major factors influencing growth of the microfluidic market is rising demand for point-of-care (POC) testing and advancements in microfluidic technology to reduce cost of sample analysis and enabling higher efficiency. Moreover, increasing demand for home healthcare to address growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance, in 2017 researchers at the Ewha Womens University developed an endocrine system on chip, based on microfluidic perfused 3D cell-culture chip which detect the drugs for the treatment of diabetes by measuring insulin release over time. According to the statistics published by International Diabetes Federation (IDF), the global prevalence of diabetes is around 424.9 million in 2017, which is expected to increase to 628.6 million in 2045. In addition, increasing innovation in microfluidics technology is further expected to bolster growth of the market. Researchers at the Brigham Young University, in April 2017, developed first 3D-print viable microfluidic device which has size less than 100 micrometers and employed to use in molecular biology, proteomics and cell biology diagnostic technologies.

Controlled drug delivery system deliver the drug at target sites, in desired quantity, and on time thus, enhancing drug efficiency, bioavailability, and pharmacokinetics while maintaining minimum side effects. Microfluidic-based devices are adopted significantly for micro and nano-scale drug delivery, maintaining the physiochemical characteristics of drug, at the target location. For instance, researchers at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and Charles Stark Draper Laboratory in Massachusetts developed microfluidic based automated micropump device for direct delivery of drugs into the perilymph fluid within the cochlea – an auditory portion of the inner ear.

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1086 

Key players in the microfluidic market are emphasizing on introducing innovative solutions based on microfluidic technology for a wide range of applications. For instance, in November 2017, Dolomite Bio introduced Nadia- a single-cell platform for single-cell RNA sequencing. Nadia is droplet microfluidic based instrument that can generate 6,000 single-cell libraries per sample in just 15 minutes. It also aids researchers to run multiple samples parallelly. Dolomite Bio combines the microfluidic technology with automated temperature control and cell/bead agitation in single instrument that delivers highly precise and reliable results. OPKO Health, Inc., in November 2017 submitted the Premarket Approval (PMA) application to US FDA for Claros 1 immunoassay analyzer. Claros 1 immunoassay analyzer is a diagnostic instrument system, which uses microfluidics technology to provide quick and quantitative blood test result in just 10 minutes by eliminating the need of external reagent, instrument calibration and maintenance.

Point-of-care testing (POC Testing) is medical diagnostic testing performed primarily outside medical care facilities and in close proximity that is at the time and place of patient care. Point-of-care testing is relatively expensive than regular lab testing; however, it offers appropriate and immediate results for further clinical management. Microfluidic technology primarily offers three advantages to POC diagnostic: smaller sample volume, lower test costs, and faster detection time. Point-of-care testing enables miniaturization and integration of complex functions facilitating their usage in limited resources.

Request Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/1086

Detailed Segmentation:

By Material Type:

Silicon-Based Microfluidic

Glass-Based Microfluidic

Polymer-Based Microfluidic

Other Materials- Based (Paper & Ceramics) Microfluidic

By Application:

In Vitro Diagnostic Devices

Drug Delivery Devices

Monitoring Devices

By Geography:

North America

By Material Type:

Silicon-Based Microfluidic

Glass-Based Microfluidic

Polymer-Based Microfluidic

Other

By Application:

In Vitro Diagnostic Devices

Drug Delivery Devices

Monitoring Devices

By Country:

U.S.

Canada

Latin America

By Material Type:

Silicon-Based Microfluidic

Glass-Based Microfluidic

Polymer-Based Microfluidic

Other

By Application:

In Vitro Diagnostic Devices

Drug Delivery Devices

Monitoring Devices

By Country:

Brazil

Mexico

Rest of Latin America

Europe

By Material Type:

Silicon-Based Microfluidic

Glass-Based Microfluidic

Polymer-Based Microfluidic

Other

By Application:

In Vitro Diagnostic Devices

Drug Delivery Devices

Monitoring Devices

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Some of the major players operating in the microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1086

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Shah
Email: Send Email
Phone: +1-206-701-6702
Address:1001 4th Ave, #3200
City: Seattle
State: Washington
Country: United States
Website: https://www.coherentmarketinsights.com/insight/buy-now/2618